Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background/objectives: A heterozygous mutation in the gene is responsible for autosomal dominant non-syndromic hearing loss (DFNA6/14/38) and Wolfram-like syndrome, which is characterized by bilateral sensorineural hearing loss with optic atrophy and/or diabetes mellitus. However, detailed clinical features for the patients with the heterozygous p.A684V variant remain unknown.

Methods: We report the clinical details of 14 cases with a heterozygous p.A684V variant in the gene identified from target resequencing analysis of 63 previously reported deafness genes by next-generation sequencing of 15,684 hearing loss patients (mean age 27.5 ± 23.1 years old, 6574 male, 8612 female and 498 for whom information was unavailable).

Results: Among the 14 patients from 13 families with the p.A684V variant, nine were sporadic cases. In addition, we confirmed de novo occurrence of this variant in seven families. This result strongly supports the notion that this variant was located on a mutational hotspot. When comparing previously reported cases of autosomal dominant gene-associated hearing loss, most of the patients in this study showed severe-to-profound bilateral sensorineural hearing loss (genotype-phenotype correlation). Two patients had optic atrophy, while the others did not have any other complications.

Conclusions: The identified heterozygous p.A684V variant appears to be a hotspot mutation and likely to cause severe-to-profound hearing loss in early childhood. Cochlear implantation is considered favorable in cases of hearing impairment due to this variant.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11764508PMC
http://dx.doi.org/10.3390/genes16010057DOI Listing

Publication Analysis

Top Keywords

hearing loss
28
pa684v variant
20
heterozygous pa684v
16
variant
8
variant gene
8
mutational hotspot
8
hearing
8
autosomal dominant
8
bilateral sensorineural
8
sensorineural hearing
8

Similar Publications

On October 17, 2022, the U.S. Food and Drug Administration (FDA) formally established a new category of hearing aids (HAs), now available over the counter (OTC).

View Article and Find Full Text PDF

Obesity and Hearing Loss: Mechanisms and Future Challenges.

Obesity (Silver Spring)

September 2025

Laboratorio de Neurociencia Sensorial, Perceptual y Cognitiva, Instituto de Ciencias de la Salud, Universidad de O'Higgins, Rancagua, Chile.

In recent years, it has been suggested that the development of obesity could affect the auditory system, altering its functionality and its ability to process sound. However, little research exists on the molecular and physiological mechanisms underlying this relationship, especially in humans. This narrative review aims to highlight the research supporting the role of obesity as both an independent risk factor for hearing loss and as a condition that may exacerbate age-related hearing loss, providing an analysis of the molecular mechanisms underlying these processes.

View Article and Find Full Text PDF

Background: Workers in industry settings are often exposed to complex noise, which poses a greater risk to hearing loss than continuous noise at equivalent energy levels. Previous studies have identified kurtosis as an essential metric for evaluating complex noise-induced hearing loss (NIHL). This study aimed to characterize the distribution of workers exposed to complex noise, examine the associations between kurtosis and changes in hearing thresholds at various frequencies, and explore kurtosis's role in estimating NIHL and its integration into occupational hearing loss prevention programs.

View Article and Find Full Text PDF

Deletion of the SHORT Syndrome Gene Prkce Results in Brain Atrophy and Cognitive and Motor Behavior Deficits in Mice.

Neurosci Bull

September 2025

Zhejiang Key Laboratory of Organ Development and Regeneration, College of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou, 311121, China.

The neurological manifestations of SHORT syndrome include intrauterine growth restriction, microcephaly, intellectual disability, hearing loss, and speech delay. SHORT syndrome is generally believed to be caused by PIK3R1 gene mutations and impaired PI3K-AKT activation. Recently, a clinical case report described a SHORT syndrome with a novel mutant in PRKCE gene encoding protein kinase Cε (PKCε).

View Article and Find Full Text PDF

Tinnitus, the auditory perception of sound without an external environmental stimulus, affects 15% of the human population and is associated with hearing loss. Interestingly, anxiety may be a significant risk factor in tinnitus pathophysiology potentially due to underlying common neural circuits of the auditory and limbic systems. The current study aimed to investigate the effects of stress-induced anxiety on tinnitus development in a rat model.

View Article and Find Full Text PDF